as on February 10, 2026 at 7:47 pm IST
Day's Low
Day's High
1.24%
Downside
2.12%
Upside
52 Week's Low
52 Week's High
6.11%
Downside
100.88%
Upside
as on February 10, 2026 at 2:17 pm IST
Market Cap
₹121.99 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
1.21
P/B Ratio
-0.98
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-59.56
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Krebs Biochemicals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 121.99 | -9.79% | 0.00 | -27 | 43 | |
| NA | 79.75 | 46.88% | 0.70 | 1 | 45 | |
| NA | 19.17 | -12.87% | 0.82 | 3 | 168 | |
| NA | 3,308.55 | 380.28% | 0.76 | 8 | 1 | |
| NA | 68.45 | -0.02% | 0.00 | 7 | 50 |
Get share price movements and forecasts by analysts on Krebs Biochemicals.
Source: S&P Global Market Intelligence
Search interest for Krebs Biochemicals & Industries Ltd Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Krebs Biochemicals.
Krebs Biochemicals & Industries Ltd’s net profit fell -6.6% since last year same period to ₹-6.14Cr in the Q2 2025-2026. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -15.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.2% return, outperforming this stock by 67.8%
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 72.74% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 26.76% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.8% return, outperforming this stock by 202.5%
Price Dip
![]()
In the last 7 days, KREBSBIO stock has moved down by -2.5%
| Organisation | Krebs Biochemicals & Industries Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | R T Ravi |
| E-voting on shares | Click here to vote |
Krebs Biochemicals share price today stands at ₹56.5 as on . Krebs Biochemicals share today touched a day high of ₹57.7 and a low of ₹55.8.
Krebs Biochemicals touched a 52 week high of ₹113.5 and a 52 week low of ₹53.05. Krebs Biochemicals share price today i.e. is trending at ₹56.5, which is -50.22% down from its 52 week high and 6.50% up from its 52 week low.
Krebs Biochemicals market capitalisation is ₹121.99 Cr as on .
To buy Krebs Biochemicals shares, you need to follow these steps:
Krebs Biochemicals trading volume is 8,715.00 as on . This means that 8,715.00 shares of Krebs Biochemicals were bought and sold on the stock market during today's trading session.